Editorial: Immunotherapy in renal cell carcinoma

This collection contains 10 reports published In Frontiers in Oncology between August 2020 and March 2022 broadly focused on the immunobiology of renal cell carcinoma (RCC), the impact of immunotherapy in the setting of RCC, and the identification of biomarkers that are prognostic of RCC patient out...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruenwald, Viktor, Storkus, Walter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363885/
https://www.ncbi.nlm.nih.gov/pubmed/35965584
http://dx.doi.org/10.3389/fonc.2022.945510
_version_ 1784765032492433408
author Gruenwald, Viktor
Storkus, Walter J.
author_facet Gruenwald, Viktor
Storkus, Walter J.
author_sort Gruenwald, Viktor
collection PubMed
description This collection contains 10 reports published In Frontiers in Oncology between August 2020 and March 2022 broadly focused on the immunobiology of renal cell carcinoma (RCC), the impact of immunotherapy in the setting of RCC, and the identification of biomarkers that are prognostic of RCC patient outcomes and response to immunotherapy.
format Online
Article
Text
id pubmed-9363885
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93638852022-08-11 Editorial: Immunotherapy in renal cell carcinoma Gruenwald, Viktor Storkus, Walter J. Front Oncol Oncology This collection contains 10 reports published In Frontiers in Oncology between August 2020 and March 2022 broadly focused on the immunobiology of renal cell carcinoma (RCC), the impact of immunotherapy in the setting of RCC, and the identification of biomarkers that are prognostic of RCC patient outcomes and response to immunotherapy. Frontiers Media S.A. 2022-07-27 /pmc/articles/PMC9363885/ /pubmed/35965584 http://dx.doi.org/10.3389/fonc.2022.945510 Text en Copyright © 2022 Gruenwald and Storkus https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gruenwald, Viktor
Storkus, Walter J.
Editorial: Immunotherapy in renal cell carcinoma
title Editorial: Immunotherapy in renal cell carcinoma
title_full Editorial: Immunotherapy in renal cell carcinoma
title_fullStr Editorial: Immunotherapy in renal cell carcinoma
title_full_unstemmed Editorial: Immunotherapy in renal cell carcinoma
title_short Editorial: Immunotherapy in renal cell carcinoma
title_sort editorial: immunotherapy in renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363885/
https://www.ncbi.nlm.nih.gov/pubmed/35965584
http://dx.doi.org/10.3389/fonc.2022.945510
work_keys_str_mv AT gruenwaldviktor editorialimmunotherapyinrenalcellcarcinoma
AT storkuswalterj editorialimmunotherapyinrenalcellcarcinoma

Ejemplares similares